Catalyst Pharmaceutical Inc.
N/A
USD
N/A
N/A
...
Chart
Financials
Description
CPRX Company Description
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.
CPRX Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view CPRX Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of CPRX by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by CPRX's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of CPRX in WallStreetBets Daily Discussion
CPRX News
Recent insights relating to CPRX
CNBC Recommendations
Recent picks made for CPRX stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in CPRX
Corporate Flights
Flights by private jets registered to CPRX
Our Analysis